Several brokerages have updated their recommendations and price targets on shares of Alcentra Capital Corp. (NASDAQ: ABDC) in the last few weeks:

  • 11/10/2017 – Alcentra Capital Corp. had its “hold” rating reaffirmed by analysts at Keefe, Bruyette & Woods. They now have a $9.50 price target on the stock.
  • 11/8/2017 – Alcentra Capital Corp. was downgraded by analysts at UBS Group AG from an “outperform” rating to an “underperform” rating.
  • 11/8/2017 – Alcentra Capital Corp. was downgraded by analysts at Rowe from an “outperform” rating to an “underperform” rating.
  • 11/8/2017 – Alcentra Capital Corp. was downgraded by analysts at Raymond James Financial, Inc. from an “outperform” rating to an “underperform” rating.
  • 10/2/2017 – Alcentra Capital Corp. was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating.

Shares of Alcentra Capital Corp. (NASDAQ:ABDC) traded up $0.10 during trading on Thursday, hitting $7.85. 141,500 shares of the stock were exchanged, compared to its average volume of 80,828. Alcentra Capital Corp. has a twelve month low of $7.00 and a twelve month high of $14.73. The firm has a market capitalization of $110.40, a PE ratio of 5.20 and a beta of 0.68.

Alcentra Capital Corp. (NASDAQ:ABDC) last issued its quarterly earnings data on Monday, November 6th. The asset manager reported $0.34 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.33 by $0.01. Alcentra Capital Corp. had a negative net margin of 2.25% and a positive return on equity of 11.32%. The business had revenue of $7.61 million during the quarter. equities research analysts anticipate that Alcentra Capital Corp. will post 1.29 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 4th. Stockholders of record on Friday, December 29th will be paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 12.74%. The ex-dividend date is Thursday, December 28th. Alcentra Capital Corp.’s payout ratio is -2,719.46%.

In related news, Director Steven H. Reiff bought 6,900 shares of the business’s stock in a transaction that occurred on Monday, November 13th. The stock was purchased at an average cost of $7.23 per share, for a total transaction of $49,887.00. Following the purchase, the director now directly owns 35,246 shares in the company, valued at $254,828.58. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, Director Paul J. Echausse sold 10,000 shares of the company’s stock in a transaction on Thursday, November 9th. The shares were sold at an average price of $7.45, for a total transaction of $74,500.00. Following the transaction, the director now owns 58,946 shares of the company’s stock, valued at $439,147.70. The disclosure for this sale can be found here. Insiders bought 11,730 shares of company stock valued at $83,956 over the last 90 days. 4.96% of the stock is owned by corporate insiders.

Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.

Receive News & Ratings for Alcentra Capital Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.